1. Academic Validation
  2. The Influence of N-Acetyl-selenomethionine on Two RONS-Generating Cancer Cell Lines Compared to N-Acetyl-methionine

The Influence of N-Acetyl-selenomethionine on Two RONS-Generating Cancer Cell Lines Compared to N-Acetyl-methionine

  • Cells. 2024 May 29;13(11):937. doi: 10.3390/cells13110937.
Joachim Greilberger 1 Philipp Stiegler 2 Michaela Greilberger 3 Reinhold Wintersteiger 4
Affiliations

Affiliations

  • 1 Division of Medicinal Chemistry, Otto Loewi Research, Medical University of Graz, 8010 Graz, Austria.
  • 2 Division of Transplantation Surgery, Medical University of Graz, 8010 Graz, Austria.
  • 3 Institut für Laborwissenschaft Dr. Greilberger, Schwarzl Medical Center, 8053 Lassnitzhoehe, Austria.
  • 4 Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, 8010 Graz, Austria.
Abstract

N-acetyl-selenomethionine (NASeLM), a representative of the selenium compounds, failed to convince in clinical studies and cell cultures that it neither inhibits Cancer growth nor has a chemoprotective effect. This study aims to find out whether NASeLM shows a growth-inhibiting property compared to the carrier substance N-Acetyl-L-methionine (NALM) on two different Cancer cells, namely Jurkat cells and MTC-SK cells.

Methods: Jurkat and MTC-SK cells were cultured in the absence or presence of varying concentrations (0-500 µg/mL) of NASeLM and NALM solutions. After 0, 24, 48, and 72 h, mitochondrial activity, Cancer cell membrane CP levels, cell growth, and Caspase-3 activity were assessed in aliquots of Jurkat and MTC-SK cells.

Results: Both substances, NASeLM and NALM, were similarly able to inhibit cell growth and mitochondrial activity of Jurkat cells in a concentration-dependent and time-dependent manner up to 70%. Only the determination of Caspase activity showed that only NASeLM was able to increase this to almost 40% compared to the control as well as the same lack of NALM. However, the experiments on MTC-SK cells showed a clear difference in favor of NASeLM compared to NALM. While NASeLM was able to reduce cell growth to up to 55%, the same amount of NALM was only at around 15%, which turned out to be highly significant (p < 0.001). The same could also be measured for the reduction in MTC-SK mitochondrial activity. Time dependence could also be recognized: the longer both substances, NASeLM and NALM, were incubated, the higher the effect on cell growth and mitochondrial activity, in favour of NASeLM. Only NASeLM was able to increase Caspase-3 activity in MTC-SK cells: at 250 µg/mL NASeLM, Caspase-3 activity increased significantly to 28% after 24 and 48 h compared to the control (14%) or the same NALM concentration (14%). After 72 h, this could still increase to 37%. A further increase in the NASeLM concentration did not result in higher Caspase-3 activity.

Conclusion: NASeLM could clearly increase Caspase-3 activity in both cell types, Jurkat or MTC-SK cells, and thus induce cell death. NALM and NASeLM showed a reduction in cell growth and mitochondrial activity in both cell lines: While NALM and NASeLM showed almost identical measurements on Jurkat cells, NASeLM was much more effective on MTC-SK than the non-selenium-containing carrier, indicating that it has additional anti-chemoprotective effects.

Keywords

N-Acetyl-L-methionine (NALM); N-acetyl-selenomethionine (NASeLM); T-cell leukemia cells (Jurkat cells); caspase-3 activity; cell growth; medullary thyroid carcinoma cells (MTC-SK); mitochondrial activity.

Figures
Products